Related Articles
Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers
Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers
The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
Prevalence of serum galectin‑1 autoantibodies in seven types of cancer: A potential biomarker
Prognostic and diagnostic significance of preoperative Jumonji domain‑containing 6 antibodies in colorectal cancer